Concepedia

Emma Gudgin

EG

Statistics

Publications

17

Citations

2.1K

H-Index

14

Active since

1997

Affiliations

University of Cambridge(Current)

Wellcome Sanger Institute

Addenbrooke's Hospital

Cambridge University Hospitals NHS Foundation Trust

Wellcome/MRC Cambridge Stem Cell Institute

Emma Gudgin is an author at University of Cambridge specializing in hematology, life sciences, and medicine.

Publications per year

1997–2025

17

Publications

17

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Mark A. Dawson, Rab K. Prinjha, Antje Dittmann et al. · Nature · 2011 · 1.5K citations · Full text

, , +10

Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia

Mark A. Dawson, Emma Gudgin, Sarah J. Horton et al. · Leukemia · 2013 · 175 citations · Full text

, , +16

Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia

Eva Diffner, Dominik Beck, Emma Gudgin et al. · Blood · 2013 · 86 citations

, , +17

Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasms

Shubha Anand, Frances Stedham, Philip Beer et al. · Blood · 2011 · 74 citations · Full text

, , +17

Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms

Shubha Anand, Frances Stedham, Emma Gudgin et al. · Blood · 2011 · 44 citations · Full text

, , +13

1–5 of 17